Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Ibuprofen
Clonmel Healthcare Ltd
M01AE; M01AE01
Ibuprofen
200 mg/5ml
Oral suspension
Product not subject to medical prescription
Propionic acid derivatives; ibuprofen
Marketed
2014-07-11
PACKAGE LEAFLET: INFORMATION FOR THE USER EASOFEN FOR CHILDREN SIX PLUS STRAWBERRY 200MG/5ML ORAL SUSPENSION IBUPROFEN FOR CHILDREN 6 TO 12 YEARS READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. - You must talk to a doctor if you do not feel better or if you feel worse after 3 days. WHAT IS IN THIS LEAFLET 1 What Easofen oral suspension is and what it is used for 2 What you need to know before you use Easofen oral suspension 3 How to use Easofen oral suspension 4 Possible side effects 5 How to store Easofen oral suspension 6 Contents of the pack and other information 1. WHAT EASOFEN ORAL SUSPENSION IS AND WHAT IT IS USED FOR Easofen oral suspension is a medicine that reduces pain and fever (non-steroidal anti-inflammatory drug, NSAID). Easofen oral suspension is used as short-term symptomatic treatment of: • mild to moderate pain. • fever. Easofen 200 mg/5 ml oral suspension is not for use in children under 6 years of age or under 20 kg. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE EASOFEN ORAL SUSPENSION This medicine is suitable for the majority of people but certain people should not use it. Talk to your doctor or pharmacist if you are unsure. DO NOT USE THIS MEDICINE • if your child is allergic to ibuprofen or any of the other ingredients of this medicine (listed in section 6) • if your child previously suffered an allergic reaction (e.g. skin rash, runny nose or wheezing/breathlessness, swelling of the lips, face, tongue or throat) AFTER TAKING ASPIRIN or OTHER NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) MEDICINES • if your child is taking any other ANTI-INFLAM Read the complete document
Health Products Regulatory Authority 16 November 2022 CRN00D6G5 Page 1 of 13 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Easofen for Children Six Plus Strawberry 200mg/5ml Oral Suspension 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 5 ml of oral suspension contains 200 mg Ibuprofen. Excipients with known effect Maltitol liquid 2.5 g/5 ml and sodium 28.97 mg/5 ml oral suspension For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Oral Suspension White to off-white suspension. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the short-term symptomatic treatment of mild to moderate pain. For the short-term symptomatic treatment of fever. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology For pain and fever: The daily dosage of Easofen 200mg/5ml oral suspension for children is 20-30mg/kg bodyweight in divided doses. Using the measuring device provided this can be achieved as follows: Child's age (weight) Quantity and method of administration Frequency (in 24 hour period) 6-9 years (20-30kg) 1 x 200ml/5ml (One 5 ml dose) 3 times 9-12 years (30-40kg) 1 x 300mg/7.5ml (5 ml + 2.5 ml) 3 times Doses should be given approximately every 6 to 8 hours. The package includes an oral syringe for oral administration of Easofen. The oral syringe is graduated in 0.25 ml steps up to 5 ml. 5 ml of oral suspension corresponds to 200 mg ibuprofen. For patients with sensitive stomachs it is recommended that Easofen 200mg/5ml oral suspension is taken during a meal. _Not intended for children under 6 years of age or under 20kg._ Method of administration For oral use. The lowest effective dose should be used for the shortest duration necessary to relieve symptoms (see section 4.4) If in children aged from 6 years this medicinal product is required for more than 3 days, or if symptoms worsen a doctor should be consulted. Health Products Regulatory Authority 16 November 2022 CRN00D6G5 Page 2 of 13 Special patient groups Renal insufficiency: (see section 5.2) No dose reduction is required in Read the complete document